pediatric patient / parent

As a physician scientist Dr. Meier always had a passion for integrating patient care with research dedicated to improving cancer treatments. Clinically He is specialized in the management of patients with hematologic malignancies who are undergoing stem cell transplantation or receiving other cellular therapies, like CAR T cells. Dr. Meier research is focused on better understanding how to fully engage the immune system in its fight against cancer. He is studying how extracellular signals in the tumor microenvironment regulate the function of immune cells with a particular interest in

I am a physician-scientist specializing in myeloproliferative neoplasms (MPN), bone marrow failure syndromes, lower risk myelodysplastic syndromes (MDS), and clonal hematopoiesis. I lead our MPN program, which was established in 2019 and provides clinical and research expertise for MPN patients. My research primarily focuses on mechanisms of thrombosis in MPN, with a goal to improve MPN care by individualizing thrombosis risk stratification and by finding better treatments to prevent thrombosis. I am also dedicated to training the next generation of physicians and am involved in medical

I am a physician-scientist who sees patients in clinic with disorders of clonal hematopoiesis and myeloid cancers, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). My clinical and research interests focus on RNA regulation in hematologic malignancies. Specifically, I investigate how mutations in splicing factors affect RNA processing and contribute to disease progression. These genetic mutations can occur at any stage of life, leading to complex disorders that are often challenging to diagnose and treat. In the laboratory, we utilize advanced genomic technologies